Alternatives to WRRisk

Accelerating the speed, precision, and affordability of cancer diagnoses is crucial, especially considering that one in three individuals will face this disease in their lifetime. Unfortunately, the current diagnostic process is often hindered by slow and costly methods, primarily due to the lack of advanced automated tools that support healthcare professionals. Qritive addresses this challenge by offering an AI-driven solution designed to assist physicians in analyzing both microscopy images and textual patient data efficiently. This innovation not only enhances the effectiveness of hospitals in diagnosing cancer but also contributes to significant cost savings. Additionally, Pantheon serves as a CE-marked, vendor-agnostic digital pathology platform that facilitates the complete digitization of pathology lab workflows and telepathology. It also supports comprehensive report generation and offers a robust platform for AI-driven analysis of whole-slide images in pathology. This technology is particularly adept at distinguishing between a variety of benign conditions and malignant diseases within breast tissue, which is vital for timely and accurate treatment. In doing so, it plays a pivotal role in transforming the landscape of cancer diagnostics.

Volpara Health software is utilized by various facilities, including leading cancer screening centers in the United States, to facilitate the early detection of breast cancer. Mammography technologists depend on this software to enhance the quality of mammograms. Recognized as the most scientifically validated screening tool in the breast health sector, Volpara provides essential evidence at critical moments. It offers access to comprehensive patient data, enabling more accurate assessments of breast cancer risk. Each analyzed image contributes to refining our algorithms for early detection of the disease. Your support is crucial in promoting additional screening or genetic tests for patients. The platform allows for the creation of tailored worklists and reports according to individual preferences. Users can simultaneously view statistics and lists from a single interface, making the process more efficient. Communication can be standardized across patients, referrers, and insurers, ensuring clarity and consistency. Furthermore, it enhances the delivery of result letters by incorporating thumbnail images of mammograms, making the information more engaging and informative. This multifaceted approach ultimately promotes better patient care and outcomes in breast health.

Explore our efficient screening tools designed to identify patients at a high risk for breast, colorectal, and other types of cancer. Progeny Clinical streamlines the management of family histories, risk assessments, and treatment options for your patients. You can gather family history information online and automatically create pedigrees prior to the clinic appointment. Modify existing pedigrees or create new ones at any time. Execute validated hereditary cancer risk assessment models with a single click, eliminating the need to re-enter data. Simplify the process by ordering genetic testing through Ambry Genetics. Monitor and analyze results from any laboratory without leaving the software environment. Enhance efficiency by generating letters, consultation notes, reports, and documents using custom templates that incorporate patient data fields. Utilize pre-configured or tailored data input screens to swiftly create custom queries and spreadsheet reports. Moreover, you can integrate a hyperlink within your electronic medical record to conveniently access the patient’s latest pedigree. This innovative approach not only saves time but also optimizes patient care and enhances workflow efficiency.

WRDensity supports radiologists in evaluating breast density, promoting consistency in density assessments across their practices. Its primary aim is to facilitate early detection while ensuring patients feel reassured through enhanced consistency, confidence, and overall quality of care. Developed using advanced deep learning techniques, WRDensity analyzed over 600,000 images sourced from the esteemed Mallinckrodt Institute of Radiology, known for its pioneering work in the field. This robust deep learning model excels in providing precise classifications of breast density. Additionally, the batching and sorting features can boost user productivity by as much as 20%. By integrating WRDensity into the radiologist's existing workstation, critical information regarding tissue density is readily accessible in a relevant context, further enhancing the diagnostic process. Ultimately, this innovation not only streamlines the workflow but also contributes to improved patient outcomes.

The integrated mammography viewer allows for ergonomic reading of a diverse range of breast imaging studies alongside other specialty examinations, all conveniently located in one interface. By streamlining workflows, it facilitates quicker reading in high-volume settings, resulting in increased patient throughput. The incorporation of Artificial Intelligence enhances physician efficiency, reduces false negatives in cancer detection, and contributes to the quality assurance of imaging results. A holistic telemammography solution serves as a vital link to expanding access to breast expertise, ultimately leading to improved diagnostic accuracy and patient outcomes. The NovaMG PRO can function as an independent workstation compatible with any PACS or mammography technology. Additionally, the breast care workflow module is included within NovaPACS EI, and current users can activate it in just a few minutes, enhancing their existing systems. This integration not only simplifies the process but also empowers healthcare professionals to deliver better care to patients.

Paige's offerings have the potential to revolutionize the practice of pathologists by instilling greater certainty in diagnoses. The company is committed to pioneering a new era of clinical tools and predictive assessments that empower pathologists while redefining the field of oncology. With its innovative AI solutions, Paige paves the way for the future of pathology. The Paige Platform serves as a comprehensive, secure solution that ensures interoperability with laboratory information systems (LIS), integrates multiple scanners, offers cloud storage, facilitates case management, enables image review through FullFocus®, and incorporates advanced AI applications. The Paige Prostate suite of AI tools is specifically designed to aid pathologists in identifying suspicious areas, grading and quantifying tissue samples, and assessing perineural invasion (PNI) in prostate needle core biopsies. Similarly, the Paige Breast suite of AI applications supports pathologists in evaluating breast cancer by enabling the identification of malignancies in breast biopsies and the detection of metastases in lymph nodes associated with breast tissue. Collectively, these advancements not only enhance diagnostic accuracy but also improve patient outcomes in oncology.

Enhancing the care quality and outcomes for individuals battling cancer necessitates a cooperative effort among healthcare providers, researchers, cancer institutions, and the patients themselves. Oncora's user-friendly software platform empowers all parties involved to gather and utilize real-world data, thereby facilitating informed healthcare decisions that prioritize patient welfare. Our solutions are specifically designed for healthcare professionals who are committed to advancing cancer treatment results. By simplifying workflows, alleviating documentation challenges, and optimizing care through smart software solutions, we enable a more efficient healthcare experience. Our intuitive tools allow for the capture and visualization of regulatory-grade real-world data, essential for informed decision-making. With sophisticated reporting capabilities, you can measure quality and enhance operations to elevate patient care. Engaging in rigorous clinical research alongside leading cancer care experts further reinforces our commitment. The intuitive, web-based software we offer is tailored to meet the needs of your cancer center, providing data and tools that expedite clinical breakthroughs and innovations. Ultimately, our mission is to transform cancer care through technology and collaboration, ensuring that patients receive the highest standard of care available.

Enhance the Patient Journey by actively engaging, educating, and empowering individuals through improved health communications. Utilize a Patient Engagement Platform to tailor optimal care plans for various medical pathways, such as prostate and breast cancer. Develop a Patient Engagement Pathway that organizes communication strategies in accordance with each care plan's requirements. Streamline the organization of communications by creating or sourcing a variety of supportive materials, including messages, documents, and videos, that correspond to different phases of the care plan. Establish clear communication rules that specify who receives which communications and at what times, ensuring timely delivery of essential information. Integrate new patients into the system effortlessly by matching their specific needs with the appropriate pathway. Finally, centralize all patient-facing communications in one location, allowing for the efficient dissemination of messages, documents, forms, videos, and health widgets. By doing so, healthcare providers can enhance the overall patient experience and foster better health outcomes.

Aiforia provides advanced deep learning and cloud-based solutions to pathologists and researchers in both preclinical and clinical laboratories, enhancing their capabilities in image analysis and workflow efficiency. By enabling scientists to discover new disease biomarkers and assisting R&D professionals in accelerating the market introduction of innovative drugs, Aiforia plays a crucial role in improving cancer diagnostic accuracy while revolutionizing healthcare from the initial discovery phase through to diagnosis. For clinical pathology laboratories seeking to boost efficiency and elevate the precision of their diagnoses, the Aiforia Clinical Suites present a comprehensive range of AI-driven diagnostic tools, intelligent visualization, quality control, and automated pre- and post-screening functionalities. We are in the process of developing specialized Suites targeting some of the most common cancers globally and have achieved CE-IVD certification for our AI solutions in lung and breast cancer, positioning us as a leader in diagnostic innovation. Our commitment to enhancing patient outcomes through technology underscores the transformative potential of our offerings in the healthcare sector.

Ibex Medical Analytics stands at the forefront of AI-driven cancer diagnostics within the field of pathology. Our diverse team comprises entrepreneurs, data scientists, software engineers, and medical professionals united in our mission to revolutionize cancer diagnostics through artificial intelligence, ultimately enhancing patient care. As the volume of tests continues to rise annually, pathologists face significant challenges in delivering precise and timely analyses. To address this, Ibex harnesses the power of AI to create clinical-grade solutions that aim to identify cancer with the same level of accuracy as a human pathologist. The Galen Platform employs advanced algorithms to scrutinize images, detect and classify cancer in biopsy samples, and highlight other clinically significant findings, thereby assisting pathologists in minimizing diagnostic errors while streamlining their workflow. Notably, Ibex’s Galen™ Prostate and Galen™ Breast solutions represent the pioneering AI-based cancer detection tools integrated into routine clinical practice in pathology labs, showcasing proven efficacy in uncovering previously missed cancer cases. As we continue to innovate, our commitment to improving cancer detection and patient outcomes remains unwavering.

My Care PlusSM enhances the healthcare experience by fostering a personal connection that allows patients to take charge of their health journey. Through the user-friendly portal, individuals can easily access their personal health records, communicate with their healthcare providers, and explore a newly expanded repository of educational resources designed for patients. Patients are granted the ability to review their comprehensive care plans, along with vital health information and educational materials on conditions and medications sourced from reputable cancer organizations, accessible at any time and from any location. They can also utilize secure messaging to address non-urgent inquiries or send broadcast messages to all patients, ensuring effective communication. To boost patient engagement with the portal, customizable marketing resources, videos, and other tools are available to raise awareness of its advantages. Additionally, the platform supports healthcare practices in achieving Meaningful Use objectives by integrating all necessary features to fulfill both stage 1 and stage 2 requirements. Furthermore, it offers robust clinical decision support, along with performance analytics to enhance practice efficiency and patient care. With this comprehensive suite of services, My Care PlusSM not only improves patient interactions but also enhances the overall quality of care provided.

Numerous choices in cancer treatment are fraught with uncertainty, and existing resources fail to assist a significant number of patients effectively. As a result, this situation contributes to preventable fatalities and the loss of billions in healthcare expenditures. Our team, which consists of experts from both computer science and oncology, is dedicated to addressing the critical challenges in cancer care using artificial intelligence. We are developing clinical-grade deep learning models that evaluate individual patient profiles and offer valuable guidance to oncologists during their decision-making processes. By placing oncologists at the forefront of our AI development, we ensure that the insights generated are not only interpretable but also actionable. Collaborating with leading academic medical institutions and community oncologists, we aim to tackle important clinical questions to improve patient outcomes. Ultimately, our goal is to enhance decision-making in cancer care and reduce the associated burdens on patients and healthcare systems.

CureMetrix harnesses the capabilities of Artificial Intelligence (AI) to enhance technology aimed at bettering disease detection and boosting cancer survival rates on a global scale. Our mission is centered on equipping radiologists with state-of-the-art tools that facilitate their assessment of mammograms, ultimately leading to enhanced clinical and financial results, as well as greater confidence for imaging centers, healthcare systems, and the patients they serve. Initial research involving thousands of images indicates that our innovative algorithm has the potential to decrease false-positive rates, which can help avoid unnecessary follow-up procedures and alleviate patient anxiety. We are committed to creating advanced technology that allows healthcare providers to detect even the smallest changes more swiftly and accurately than ever before. Our image analysis platform is specifically engineered to enhance the evaluation of dense breast tissue through mammography, thereby improving diagnostic accuracy and patient care. As we continue to refine our technology, we remain focused on the impact it can have on the future of medical imaging and patient outcomes.

Artrya collaborates with healthcare facilities that treat chest pain patients to introduce innovative cardiovascular care models powered by artificial intelligence. This approach seamlessly incorporates high-prognostic plaque characteristics into the assessment of coronary artery disease. It enables swift evaluations of chest pain patients in both emergency and primary care environments. Our vision is a society free from the burden of heart attacks. Leveraging AI-generated insights from coronary computed tomography angiography (CCTA), we can rapidly and accurately classify chest pain patients based on the type and quantity of arterial plaque identified. This allows for quick identification of individuals with little to no coronary artery disease, ensuring that no underlying plaque issues could lead to significant cardiac events in the future. By recognizing early indicators of potential heart attacks, we can effectively confirm at-risk patients with acute or unusual chest pain who may require additional investigation and treatment. Ultimately, this advancement aims to enhance patient outcomes and foster a healthier community.

Mamosis offers a cutting-edge AI-powered cancer diagnosis solution that accelerates and improves diagnostic accuracy by analyzing complex medical images and wellness metrics. The platform’s deep learning algorithms, developed with input from clinical experts, identify subtle patterns and anomalies that aid in early cancer detection. Mamosis delivers detailed, easy-to-interpret reports quickly, allowing clinicians to initiate timely interventions. The user-friendly interface streamlines the diagnostic process, enabling secure uploads and fast analysis, saving valuable time in clinical settings. With stringent data encryption and privacy protocols, patient information is protected at every step. Mamosis not only aids medical professionals but also empowers individuals by providing personalized health insights for proactive wellness management. The software integrates seamlessly into existing workflows, enhancing efficiency without disrupting daily operations. By fostering collaboration between AI and human expertise, Mamosis drives more accurate diagnoses and improved patient care.

Join AI is transforming the healthcare landscape with AI-powered tools designed to assist in radiology and endoscopy diagnostics. The platform offers AI-driven solutions for chest imaging, breast imaging, stroke detection, and gastrointestinal endoscopy, enabling clinicians to detect conditions like lung diseases, breast tumors, and gastrointestinal infections more efficiently. Join AI’s algorithms provide deeper insights, aiding in early diagnosis and faster decision-making, which are crucial for improving patient care and treatment outcomes. With seamless integration into existing workflows, the platform empowers healthcare professionals to make more confident decisions.

See-Mode Technologies is a MedTech firm focused on utilizing AI to enhance ultrasound reporting, thereby boosting both diagnostic accuracy and operational efficiency. Their innovative platform swiftly analyzes ultrasound images of the thyroid and breast, resulting in rapid and precise radiology reports. By identifying, measuring, and characterizing nodules, See-Mode produces a comprehensive TI-RADS sonographer worksheet along with initial impressions for radiologists. In the realm of breast imaging, the software not only detects lesions but also automates the BI-RADS reporting process, offering detailed insights into lesion characteristics and levels of suspicion. This advanced technology minimizes inter-operator variability and reduces the likelihood of reporting errors, ultimately strengthening diagnostic confidence and ensuring consistency. By streamlining the reporting process, See-Mode facilitates more informed clinical decisions, which can lead to better patient outcomes.

Revolutionize your integrated health care practice, focusing on one user at a time. Axiom’s design, centered around progress notes, enhances operational efficiency significantly. Prevent undercoding with our user-friendly coding recommendation tool. Monthly statistics are tracked with clinical decision support tools and analytics. Axiom empowers practitioners with health intelligence and decision support systems that help in effectively organizing and analyzing data for accurate disease diagnosis. Enhanced analytical capabilities can also result in substantial cost reductions. Dive deep into data to observe care trends, evaluate the financial implications of value-based payments, monitor key performance indicators, and pinpoint patients who are not keeping up with their screenings. Additionally, identify risks of readmission, receive patient updates and intervention alerts, and highlight the most impactful opportunities both financially and clinically, while also launching preventive outreach when necessary. Furthermore, real-time alerts inform providers about patients' adherence to medication regimens, significantly improving overall patient safety and care outcomes. This comprehensive approach ensures that health care providers are better equipped to address patient needs proactively.

AI plays a crucial role in identifying early-stage cancers, facilitating prompt interventions that enhance survival prospects. Cancer's intricate nature means that each type carries distinct characteristics, packed with extensive data that requires thorough analysis. This is where AI excels, leveraging its capabilities to process complex information, ultimately revealing insights that can significantly aid in cancer treatment strategies. Equipped with precise and relevant data, we take proactive steps in our battle against cancer. By utilizing AI, we are poised to make substantial strides in overcoming this disease. Our AI technology is designed to detect early-stage cancer with remarkable accuracy, achieving detection rates between 97-99%. It proficiently identifies ten of the most prevalent abnormalities found in chest x-rays, thus enhancing one of the most fundamental diagnostic tools. This innovation not only streamlines the radiology workflow but also alleviates the workload for radiologists. Lunit INSIGHT CXR successfully encompasses a wide range of findings, ensuring that we are prepared to tackle the challenges presented by cancer detection and treatment. The future of cancer care looks promising with AI at the forefront of these advancements.

Odyssey, our clinical decision support system, plays a crucial role in ensuring that patients experiencing urgent and primary care health issues receive timely, precise, and safe evaluations and recommendations. It caters to individuals of all ages and addresses a comprehensive spectrum of symptoms and acute health conditions. By enhancing the skills of healthcare providers’ personnel, it promotes a diverse skill mix among the workforce and ensures uniformity in care delivery. Healthcare professionals utilize Odyssey in various environments, such as ambulance services, out-of-hours clinics, general practitioner offices, and walk-in centers. As the population ages and faces increasingly complex health challenges, healthcare systems experience heightened strain. It is essential that those exhibiting the most urgent symptoms are prioritized for immediate intervention. Moreover, the rise in individuals managing multiple chronic conditions poses a significant risk of rapid health decline, necessitating thorough and holistic assessments to address their diverse needs effectively. This approach not only improves patient outcomes but also fosters a more efficient healthcare system capable of managing the growing complexities of modern health challenges.

We are confident that Waveform AI has the potential to significantly enhance the healthcare landscape, and we are developing a platform designed to equip clinicians with essential information and support throughout the entire care continuum. Transforming healthcare truly requires collective effort, and to play our part in advancing the industry, we are publishing peer-reviewed research on AI to illustrate its benefits at every stage of the patient care experience. Our platform aims to assist providers in identifying individuals at high risk for sleep apnea by leveraging data from electronic medical records, waveforms, wearables, and various other sources, facilitating timely referrals for diagnosis. By utilizing this data, we can aid healthcare providers in pinpointing the most critical patients among the vast undiagnosed population, categorizing them based on their risk for adverse outcomes and potential healthcare costs. Additionally, we strive to streamline the diagnostic process for clinicians, enabling them to treat more patients efficiently and effectively by improving the overall quality and speed of sleep apnea diagnoses. In doing so, we hope to foster a healthier future for all patients.

AviTracks-DM is an online clinical decision support system specifically designed for the management of patients with various chronic conditions. It features an automated workflow along with real-time integration of electronic medical records (EMR) and laboratory interfaces, making it an essential tool for hospitals, health systems, and large specialty clinics that cater to high-acuity patients, where timely information is crucial for improving patient outcomes. This system simplifies the process of enhancing care quality for high-risk individuals, facilitates smoother information exchange, and allows for the management of a greater number of patients without necessitating an increase in staffing. AviTracks-DM continuously updates the status of each patient, covering aspects such as pending lab results, labs that require review, critical alerts, and follow-up reminders. Additionally, it offers built-in and customizable reports to generate the necessary documentation for compliance with quality initiatives and pay-for-performance standards, ultimately contributing to more effective patient management. With its comprehensive capabilities, AviTracks-DM stands out as a valuable asset in the healthcare landscape, ensuring that providers are always equipped with the most current data.

Oncoustics is pioneering the development and application of innovative, patented AI technologies aimed at providing low-cost, non-invasive surveillance, diagnostics, and treatment monitoring for diseases that currently face significant clinical challenges. The company has developed a range of specialized applications focused on various diseases and anatomical structures that are compatible with any point-of-care ultrasound device, allowing physicians, nurses, and technicians to operate them as essential tools in a primary care setting without requiring image analysis. By leveraging AI, Oncoustics transforms affordable point-of-care ultrasound machines into robust diagnostic instruments capable of facilitating quick and economical identification and monitoring of conditions affecting the liver, prostate, kidney, breast, and thyroid. The multidisciplinary team behind Oncoustics consists of professionals with expertise in AI, signal processing, radiology, hepatology, digital health, and ultrasound, ensuring a comprehensive approach to healthcare innovation. The emphasis on cost-effective point-of-care diagnostics and surveillance significantly enhances patient outcomes through timely detection and consistent monitoring, which are crucial for effective disease management and better overall health. As such, Oncoustics is not only addressing immediate healthcare needs but is also setting the stage for a transformation in how we approach disease management in the future.

Grounded in established medical science and transparent systems biology, DARA enhances clinical decision-making and intervention strategies. Collaborating with healthcare providers and relevant stakeholders, we deliver digital solutions that revolutionize health screening and the management of chronic diseases. Our approach facilitates the digital evolution of care delivery through the automation of clinical workflows and the use of predictive analytics, all aligned with leading clinical guidelines and best practices. By offering actionable health insights through tailored predictions of disease risk and potential adverse events, we empower physicians to better connect with their patients. Additionally, we support pharmaceutical development by uncovering pharmacodynamics within intricate biological systems and discovering innovative therapeutic options. Utilizing predictive analytics on comprehensive patient data allows for personalized precision medicine, particularly in managing cardiometabolic diseases to avert severe patient outcomes. With our tools, healthcare can become more proactive and responsive, ultimately leading to improved patient care and health outcomes.

Color delivers one of the most user-friendly, high-quality genetic testing services currently on the market, examining genetic markers linked to the likelihood of developing prevalent cancers and heart diseases, as well as how individuals metabolize specific medications. Our comprehensive range of services, tools, and expertise is designed to facilitate the enrollment of new patients and guide them through personalized care journeys that evolve over time. By taking a holistic approach to patient health, we integrate genetic data, personal and family medical histories, along with lifestyle and behavioral factors to identify and suggest tailored care options or solutions that align with each patient's unique risk profile. This multifaceted strategy ensures that patients receive relevant recommendations that can significantly impact their health outcomes.

PEPID has been providing web-based point of care solutions for healthcare professionals for more than 20 years. These solutions allow them to accurately dose patients and diagnose medical conditions, as well as detect drug interactions and allergic reactions. PEPID products are integrated into the systems of hospitals, universities, schools, and clinics around the globe. PEPID simplifies medical information with a built-in workflow that was developed over years of interaction with pharmacists, doctors, and nurses. This unmatched organization allows healthcare professionals to have faster access and better clinical performance. It also gives them greater mobility. PEPID is used by schools to improve learning in the classroom, clinical, or study setting. PEPID is a better risk management system, greater productivity, and higher staff and patient satisfaction.

Medical AI represents a groundbreaking technological advancement that effectively tackles chronic illnesses. This innovative solution is distinguished by its capabilities to forecast outcomes, recommend optimal subsequent actions, and deliver information in a user-friendly manner. DeLorean Medical AI enhances human decision-making, paving the way for a future where both machines and humans collaboratively achieve superior results. Our technology not only enhances health outcomes but is also the first AI system to receive biological validation through independent clinical evaluations. By improving the classification of patient demographics, assessing risk factors, and forecasting transitions in disease states, Medical AI plays a crucial role in the early detection and diagnosis of various health conditions. Additionally, it contributes to cost reductions within healthcare systems. With over ten clients already utilizing our solution, it has proven effective in generating savings and reducing costs through real-time analytics that identify at-risk populations and provide next-best-action suggestions grounded in statistical evidence. Furthermore, as the healthcare landscape continues to evolve, the integration of such advanced technologies will become increasingly vital in ensuring better patient care and resource management.

Posos, a leading AI clinical-decision-support solution, helps clinicians customize every prescription to the patient profile using up-to date and multi-sources of medical data. Posos reduces the workload of providers while improving patient safety. It does this by comparing evidence-based data with EHR data to identify iatrogenic risk and reduce over-alerting. It offers potential drug substitutions that minimize side effects for the same or similar conditions. Posos API modules can be seamlessly incorporated into EHR software or ePrescription software. It has been successfully embedded in 15 EHRs and EMRs. It is based on the first native SNOMED-structured multilingual medical database.

Carevive provides a cancer care management platform that is integrated with electronic health records (EHR) to improve patient outcomes across the entire cancer treatment process. This innovative platform streamlines treatment planning by gathering patient preferences, evaluating interests in clinical trials, and tackling both physical and psychosocial challenges to enhance decision-making processes. During the active treatment phase, Carevive supports remote monitoring of symptoms through electronic patient-reported outcomes (ePROs), offering personalized symptom management plans and evidence-based pathways that aim to elevate quality of life and minimize hospital admissions. After treatment concludes, the platform continues to monitor patient-reported late effects and organizes essential care, which includes diagnostic assessments to identify new or recurring cancers. Furthermore, Carevive's analytics provide insights into aggregated patient experience data, aiding in ongoing quality enhancement and contributing to practical research in oncology. This comprehensive approach ensures that patients receive holistic support throughout their cancer journey, ultimately leading to better health outcomes.

Nuance Performance Analytics enhances clinical, financial, and patient outcomes by offering real-time data analytics and decision support systems tailored for quality management, CDI leadership, and patient safety teams to effectively monitor, evaluate, and benchmark their performances. This comprehensive web-based solution integrates the most up-to-date regulatory, payment, and reporting guidelines, presenting a variety of customizable options that facilitate risk analysis and pinpoint areas for potential improvement. Unlike other systems that update data weekly or monthly, this platform refreshes data daily across all criteria, serving as a unified source for care team members to gain insights into various populations and their performances. It also allows for the identification of emerging trends through visual representations of performance opportunities, and it connects inpatient and outpatient outcomes to identify major complications and comorbidities that qualify as hierarchical condition categories. By providing easily customizable reports that cater to the diverse requirements of stakeholders from the boardroom to the bedside, Nuance Performance Analytics ensures that all levels of the organization can access the information they need to drive quality improvements. This adaptability makes it a vital tool in the ongoing effort to enhance healthcare delivery.

The RAMP Administrator serves as an electronic medical record system designed to effectively manage patient information. Its CDS Researcher, recognized with an EU award, is an innovative AI decision support tool that assists physicians in determining the most suitable treatments for their patients. Our commitment to utilizing cutting-edge technology empowers healthcare professionals in their decision-making processes. We prioritize fairness and transparency in all our operations and ensure that patient data remains confidential and is never sold. Additionally, we focus on user-friendliness, aiming to provide solutions that address issues comprehensively. The CDS Researcher functions in two key capacities: as a researcher alert system and as an interface for researchers. The Researcher Interface provides direct access to assistance for challenges related to diagnosis and therapy selection, while the Researcher Alert System continuously monitors patient data, alerting doctors to potential near misses and emphasizing pertinent information derived from AI analysis. This dual approach offers essential support for clinical decision-making, making the process smarter, more accessible, and straightforward for healthcare providers. Ultimately, our goal is to enhance patient care through intelligent technological solutions.

Enhance patient care by using the only objective, quantitative arterial analysis software validated through histology and based on CTA technology. This innovative tool employs ground-truth histological data to reveal the origins of myocardial ischemia, helping to assess risks for heart attacks and strokes. These critical events are often driven by unstable, non-obstructive plaques within the arteries that remain undetected and unaddressed. Traditional non-invasive diagnostic methods fall short, as they cannot penetrate deep into the arterial walls where heart disease begins to manifest. Elucid is leveraging advanced scientific imaging alongside artificial intelligence to facilitate rapid, reliable, and non-invasive diagnoses, ultimately leading to tailored treatment strategies for cardiovascular conditions and improved patient outcomes. With this histology-validated software, you can evaluate plaque composition and determine the risks of heart attacks and strokes with unmatched precision. This comprehensive, objective visualization of arterial health empowers healthcare providers to devise customized treatment approaches well before a patient arrives for hospital care, significantly enhancing the quality of healthcare delivery.

We assist in standardizing the contouring of organs at risk and automating segmentation in radiotherapy, which enhances the efficiency of cancer treatment planning. By adhering to established consensus guidelines, we ensure that the contours you create are more reliable. Every clinic requires a robust standard, and we take charge of implementing it on your behalf. Our fully automated 3D organ models can be generated in just a minute, significantly reducing the time spent on manual processes. This allows you to concentrate on more intricate delineation tasks rather than squandering valuable resources. Manual contouring often suffers from inter-observer variation, a challenge we address by providing consistent results. As a result, you can effectively reduce the negative consequences that stem from errors in the delineation of anatomical structures. With a single software solution that complies with GDPR regulations, the process of radiotherapy treatment planning has never been more straightforward. Our cloud-based AI model is designed to integrate effortlessly with all hospital systems, enhancing your workflow. MVision AI stands out as an innovative provider of cloud-based software services specifically for radiotherapy treatment planning, setting a new standard in the field. This approach not only improves accuracy but also promotes better patient outcomes in the long run.

75Health is an innovative electronic health record (EHR) platform hosted in the cloud, designed to assist healthcare providers in small to medium-sized clinics with the organization and management of patient data and digital files. Its primary functionalities encompass a comprehensive scheduler, medication list tracking, automated email notifications, and options for monitoring diagnostic tests and vaccinations, among other tools. Healthcare professionals can conveniently upload and keep patient records and various practice documents, such as consent forms, educational materials, and imaging results. The platform also allows users to digitize information related to allergies, current medications, laboratory findings, and symptom checklists while facilitating the development of tailored patient care plans that include tests and protocols. In addition to these features, 75Health supports e-prescribing, enabling healthcare workers to send electronic prescriptions and handle patient billing statements efficiently. The solution also incorporates clinical decision support, providing crucial insights into patient allergies, recommended drug dosages, and more, while also offering reminders to patients regarding overdue tests. Furthermore, 75Health ensures that users have access to assistance through multiple channels, including email and phone support, thereby enhancing the overall user experience. This comprehensive support system helps medical professionals navigate the complexities of patient care more effectively.

Limbic is an innovative clinical-AI platform specifically designed for behavioral health professionals that improves patient accessibility, speeds up assessments, and aids in therapy with reliable AI-driven tools. It integrates seamlessly into referral systems, offering Limbic Access, an interactive intake and screening agent that carries out evaluations, forecasts diagnoses, assesses risk levels, and produces comprehensive clinical reports for healthcare providers. In addition, Limbic provides Limbic Care, an AI companion for patients that offers structured CBT interventions, conversational check-ins, and ongoing support tailored to the individual's therapeutic plan. Central to this platform is the Limbic Layer, a proprietary clinical engine that operates between users and an extensive language model, ensuring safety, clinical accuracy, adherence to regulations, and uniformity. The platform's efficacy is underscored by its impressive diagnostic precision and is supported by peer-reviewed research and recognized regulatory endorsements, including its classification as a Class IIa medical device. Furthermore, Limbic's commitment to enhancing mental health treatment reflects a broader trend in healthcare towards integrating technology for improved patient outcomes.

Complion's platform was designed for clinical researchers. Our solution ensures compliance at the highest level with the lowest effort and the most efficiency. This allows you to concentrate on what really matters: improving and advancing patient outcomes. Our eReg solution is available to all clinical trial stakeholders, whether you are a Sponsor, Research Site or CRO. Reduce costs, avoid redundancy and increase staff productivity. You can easily archive, view and get signatures from any device. An audit trail is built into the system to ensure accuracy and eliminate patient safety risks and study conduct. Our clients include hospitals, cancer centers, and medical centers as well as multi-specialty clinics and dedicated research sites.

Noona® offers a comprehensive management solution for patient outcomes that actively involves patients in their treatment through immediate symptom reporting and monitoring, enhanced clinical workflows that support evidence-based practices, and access to extensive data insights for improved ongoing care management. Patients have the freedom to report their symptoms, fill out questionnaires, and engage with their healthcare teams whenever they wish. This approach enables care teams to gather highly specific and detailed data tailored to each patient's diagnosis and treatment plan, facilitating better-informed decision-making. With the benefit of automated prioritization, healthcare providers can identify and respond to patients who require urgent attention. The platform features over 31 treatment modules that encompass more than 97 prevalent cancer types, complemented by 244 algorithms that assess symptom severity according to established guidelines. Additionally, its remote deployment capabilities ensure quick implementation and immediate access for patients to start using the system. This innovative solution ultimately enhances the overall quality of patient care and outcomes throughout the treatment journey.

Discover enhanced chiropractic resources designed to improve diagnostic and treatment strategies. With a unified virtual platform, ChiroUp offers immediate access to evidence-based guidelines for practitioners. This innovative software streamlines the processes of diagnosis, treatment recommendations, and marketing of patient outcomes, making it an essential tool for chiropractors. Stay informed with the latest best practices covering more than 100 conditions. Elevate patient compliance and satisfaction levels effortlessly. Track patient feedback and treatment results with ease and share customized condition reports with your patients in mere moments. Access video demonstrations for various evaluations, techniques, and exercises to enhance your practice. Utilize intuitive surveys to inform and guide your clinical decisions effectively. Benefit from smart intake forms that gather essential demographic and insurance information. Gather valuable insights through intuitive disability, pain level, and post-care surveys. Monitor your clinic's performance with a comprehensive dashboard that showcases clinical outcomes and patient satisfaction metrics. Gain a clear understanding of your clinic's standing through extensive reporting tools that provide complete visibility into provider statistics. This resource not only supports practitioners but also fosters better communication with patients, ultimately enhancing overall care quality.

Transform your healthcare experience with the revolutionary Soliton® AI, which is powered by 30,000 evidence-based rules and advanced machine learning techniques. By automating various healthcare and care management functions, Soliton® equips you with the tools necessary to thrive in a value-based care environment, offering unmatched capabilities. It efficiently analyzes vast amounts of patient data in real-time, leading to enhancements in both clinical outcomes and financial performance, while also supporting a range of Alternative Payment Models (APMs). The solution boosts the effectiveness of telehealth by forecasting billable codes during patient interactions and predicting future healthcare costs through sophisticated risk stratification models. Furthermore, it provides timely clinical decision support to assist in managing intricate patient populations. Soliton® optimizes the patient journey, facilitating seamless transitions from acute to post-acute care through AI-driven care coordination. Moreover, it identifies care gaps, uncovers service and coding opportunities, and generates tailored patient assessments and personalized care plans, while also enabling the creation of custom cohorts for targeted interventions. As a result, Soliton® not only enhances operational efficiency but also elevates the overall quality of patient care.

Cleerly is a pioneering digital health organization that is revolutionizing how healthcare professionals manage heart disease. Our innovative clinical technologies are designed to enable clinicians to detect and accurately characterize atherosclerosis at an earlier stage, allowing for the development of customized and potentially life-saving treatment strategies for patients throughout their healthcare journey. Rather than relying on indirect indicators like risk factors or symptoms, we focus on measuring atherosclerosis directly, which is the accumulation of plaque in the arteries of the heart. By utilizing our AI-driven digital care pathways, we provide streamlined, rapid, and precise diagnostics and reporting that cater to the needs of all stakeholders, leading to enhanced clinical and financial results. Cleerly equips healthcare providers to transcend conventional assessments of heart disease by thoroughly analyzing, characterizing, and quantifying various plaque types. This advanced approach enables clinicians to better assess a patient's likelihood of experiencing a heart attack and to formulate effective treatment plans that aim to enhance overall heart health, ultimately fostering improved patient outcomes and quality of care.

When it's time to connect with your patients, Navigesia is here to assist you. Our platform provides real-time patient data collection alongside a variety of clinical decision support tools, enabling you to deliver Value-Based Care effectively within your practice. We offer an innovative solution that allows patients to use electronic tablets in the waiting area to fill out forms and health-related surveys. This not only enhances the patient experience but also streamlines your practice's operations. By integrating patients into the software as a valuable resource, you can effortlessly gather the high-quality information that matters to you. Embrace creativity to leverage the insights gained for improving your practice. Engage in data-rich reporting incentives and start reaping the rewards of the valuable insights your patient data can provide. Don't miss out on potential revenue; optimize your operations and maximize the benefits of your efforts. By doing so, you'll create a more efficient and rewarding environment for both your patients and your practice.

OM1 leverages artificial intelligence and extensive clinical data to significantly enhance research productivity and clinical decision-making via high-performance predictive models. The OM1 Patient Finder employs advanced AI technology seamlessly integrated with the OM1 Real-World Data Cloud. By merging various aspects of patient journeys from diverse data sources, it effectively identifies individuals most likely to be affected by the target condition. We have developed an intelligent data cloud that allows various healthcare stakeholders to access, analyze, and utilize outcomes data in a manner that is not only more comprehensive but also clinically relevant and precise. This enables rapid, accurate, and cost-effective access to research-grade insights regarding effectiveness, value, and safety. Moreover, it allows for the quantification of outcomes, facilitating the demonstration of value in risk-sharing and outcomes-based payment models. As a result, healthcare providers can make informed decisions grounded in real-world evidence.

Sword Health stands out as a prominent digital solution for musculoskeletal issues, merging artificial intelligence with professional clinical knowledge to offer individualized support for those grappling with acute, chronic, or post-surgical pain. Their extensive platform features a variety of services, including a digital physical therapy program that connects users with licensed physical therapists and harnesses real-time insights from their AI assistant, Phoenix, allowing patients to receive in-clinic advantages from the ease of their homes. Additionally, Sword Health caters to women's health by offering specialized pelvic care with programs tailored by experts in the field, which can be accessed at any time from any location. To enhance overall movement health, the platform develops personalized strategies aimed at alleviating mild pain, minimizing injury risks, and addressing issues linked to a sedentary lifestyle. Furthermore, Sword Health employs advanced AI technology to pinpoint members who may be at elevated risk for unnecessary surgical procedures, thereby promoting better health outcomes. By utilizing these innovative methods, Sword Health is redefining how individuals approach their musculoskeletal health.

Assist healthcare professionals in prioritizing patient care over paperwork, thereby reintroducing fulfillment into medical practice, reclaiming personal time, and improving care quality by highlighting the importance of the physician-patient interaction. The Oracle Health Clinical Digital Assistant serves as an AI-driven voice assistant that captures essential aspects of the physician-patient dialogue, processes this information, and drafts notes within the Oracle Health electronic health record system for the physician's quick assessment and approval. It allows users to pose questions in everyday language to retrieve patient information and carry out routine clinical tasks efficiently. Furthermore, it creates preliminary clinical notes based on patient data and discussions for the physician's evaluation and endorsement. By utilizing voice commands, practitioners can easily add to and modify patient records, ensuring that clinical documentation remains accurate and up-to-date. This innovative tool ultimately aims to streamline the documentation process, allowing physicians to focus more on their patients and less on administrative tasks.

Omda Cytodose, an oncology medication management solution from Omda, employs clinically validated protocols along with patient-specific parameters to ensure safer and more effective treatments for individuals battling cancer. This innovative system enhances the quality of care provided to oncology patients by fostering a seamless and collaborative treatment process among healthcare professionals, including doctors, pharmacists, and nurses. Omda Cytodose is designed to support a comprehensive range of adult and pediatric cancers, accommodating various medical treatments such as chemotherapy, immunotherapy, hormone therapy, and additional supportive medications. Initially created by a team of clinicians at one of Norway's premier cancer centers and introduced in 2001, Omda Cytodose has gained widespread adoption across healthcare regions in the Nordic countries, leading to the fulfillment of millions of medication orders. With a robust 15-year history marked by stability, reliability, and safety, the system is meticulously configured with chemotherapy protocols that reflect both national and international guidelines. This ensures that patients receive the most up-to-date treatment options available, further enhancing their chances of successful outcomes.